Entity Central Index Key
Accumulated gross unrealized gain before tax available for sale securities.
Cover [Abstract]
Document Type
Document Type
Amendment Flag
Amendment Flag
Document Period End Date
Document Period End Date
Document Fiscal Year Focus
Document Fiscal Year Focus
Document Fiscal Period Focus
Document Fiscal Period Focus
Trading Symbol
Trading Symbol
Entity Registrant Name
Entity Registrant Name
Entity Central Index Key
Current Fiscal Year End Date
Current Fiscal Year End Date
Entity Well-known Seasoned Issuer
Entity Well Known Seasoned Issuer
Entity Current Reporting Status
Entity Current Reporting Status
Entity Voluntary Filers
Entity Voluntary Filers
Entity Filer Category
Entity Filer Category
Entity Shell Company
Entity Shell Company
Entity Small Business
Entity Small Business
Entity Emerging Growth Company
Entity Emerging Growth Company
Entity Common Stock, Shares Outstanding
Entity Common Stock Shares Outstanding
Entity Public Float
Entity Public Float
ICFR Auditor Attestation Flag
Icfr Auditor Attestation Flag
Entity Interactive Data Current
Entity Interactive Data Current
Title of 12(b) Security
Security12b Title
Security Exchange Name
Security Exchange Name
Entity File Number
Entity File Number
Entity Incorporation, State or Country Code
Entity Incorporation State Country Code
Entity Tax Identification Number
Entity Tax Identification Number
Entity Address, Address Line One
Entity Address Address Line1
Entity Address, Address Line Two
Entity Address Address Line2
Entity Address, City or Town
Entity Address City Or Town
Entity Address, State or Province
Entity Address State Or Province
Entity Address, Postal Zip Code
Entity Address Postal Zip Code
City Area Code
City Area Code
Local Phone Number
Local Phone Number
Document Annual Report
Document Annual Report
Document Transition Report
Document Transition Report
Auditor Firm ID
Auditor Firm Id
Auditor Name
Auditor Name
Auditor Location
Auditor Location
Contingent value rights derivative liability.
Statement Of Financial Position [Abstract]
Statement [Table]
Statement [Table]
Class of Stock
Statement Class Of Stock [Axis]
Class of Stock
Class Of Stock [Domain]
Redeemable Convertible Preferred Stock
Redeemable Convertible Preferred Stock [Member]
Statement [Line Items]
Statement [Line Items]
Assets
Assets [Abstract]
Current assets:
Assets Current [Abstract]
Cash and cash equivalents
Cash And Cash Equivalents At Carrying Value
Short-term investments
Short Term Investments
Accounts and other receivables
Accounts And Other Receivables Net Current
Prepaid and other current assets
Prepaid Expense And Other Assets Current
Total current assets
Assets Current
Other assets, noncurrent
Other Assets Noncurrent
Right-of-use assets
Operating Lease Right Of Use Asset
Property and equipment, net
Property Plant And Equipment Net
Total assets
Assets
Liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit)
Liabilities And Stockholders Equity [Abstract]
Current liabilities:
Liabilities Current [Abstract]
Accounts payable
Accounts Payable Current
Accrued compensation
Accrued Employee Benefits Current
Deferred revenue
Deferred Revenue Current
Other accrued liabilities
Other Accrued Liabilities Current
Dividends payable
Dividends Payable Current
CVR derivative liability
Contingent Value Rights Derivative Liability
Operating lease liability
Operating Lease Liability Current
Total current liabilities
Liabilities Current
Operating lease liability, noncurrent
Operating Lease Liability Noncurrent
Total liabilities
Liabilities
Commitments and Contingencies (Note 8)
Commitments And Contingencies
Redeemable convertible preferred stock, $0.001 par value, 123,418 shares authorized; 12,340 shares issued and outstanding as of December 31, 2022 and no shares issued and outstanding as of December 31, 2021
Temporary Equity Carrying Amount Attributable To Parent
Stockholders’ equity (deficit):
Stockholders Equity [Abstract]
Common stock, $0.001 par value, 100,000,000 shares authorized; 37,756,574 and 31,409,707 shares issued and outstanding at December 31, 2022 and 2021, respectively
Common Stock Value
Additional paid-in capital
Additional Paid In Capital
Accumulated deficit
Retained Earnings Accumulated Deficit
Total stockholders’ equity (deficit)
Stockholders Equity
Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit)
Liabilities And Stockholders Equity
Redeemable Convertible Preferred Stock
Temporary equity,par value
Temporary Equity Par Or Stated Value Per Share
Temporary equity, shares authorized
Temporary Equity Shares Authorized
Temporary equity, shares issued
Temporary Equity Shares Issued
Temporary equity, shares outstanding
Temporary Equity Shares Outstanding
Common stock, par value
Common Stock Par Or Stated Value Per Share
Common stock, shares authorized
Common Stock Shares Authorized
Common stock, shares issued
Common Stock Shares Issued
Common stock, shares outstanding
Common Stock Shares Outstanding
Interest and other income (expense), net.
Income Statement [Abstract]
Product and Service
Product Or Service [Axis]
Product and Service
Products And Services [Domain]
Collaboration revenue member.
Collaboration
Collaboration Revenue [Member]
Cost of collaboration.
Cost of collaboration
Cost Of Collaboration [Member]
Revenue:
Revenues [Abstract]
License and collaboration revenue
Revenue From Contract With Customer Excluding Assessed Tax
Operating expenses (income):
Operating Expenses [Abstract]
Cost of license and collaboration
Cost Of Goods And Services Sold
Research and development
Research And Development Expense Excluding Acquired In Process Cost
General and administrative
General And Administrative Expense
Acquired in-process research and development
Research And Development In Process
Gain on disposal of assets, net
Gain Loss On Disposition Of Assets1
Total operating expenses
Operating Expenses
Loss from operations
Operating Income Loss
Interest and other income (expense), net
Interest And Other Income Expense Net
Loss before income taxes
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
Income tax expenses
Income Tax Expense Benefit
Net loss
Net Income Loss
Net loss per share attributable to common stockholders, basic
Earnings Per Share Basic
Net loss per share attributable to common stockholders, diluted
Earnings Per Share Diluted
Shares used to compute net loss per share attributable to common stockholders, basic
Weighted Average Number Of Shares Outstanding Basic
Shares used to compute net loss per share attributable to common stockholders, diluted
Weighted Average Number Of Diluted Shares Outstanding
Cash dividends paid per common share
Common Stock Dividends Per Share Cash Paid
Cash dividends declared, unpaid, per common share
Common Stock Dividends Per Share Declared
Statement Of Income And Comprehensive Income [Abstract]
Net loss
Other comprehensive loss:
Other Comprehensive Income Loss Net Of Tax Period Change [Abstract]
Unrealized loss on available-for-sale debt securities
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
Total comprehensive loss
Comprehensive Income Net Of Tax
Stock issued during period from stock grants and stock options exercised, value.
Stock issued during period from stock grants and stock options exercised, shares.
Temporary equity issued during period shares acquisitions.
Temporary equity issued during period value acquisitions.
CVR derivative liability.
Statement Of Stockholders Equity [Abstract]
Additional Paid-In Capital
Statement Equity Components [Axis]
Equity Component
Equity Component [Domain]
Common Stock
Common Stock [Member]
Additional Paid-In Capital
Additional Paid In Capital [Member]
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit
Retained Earnings [Member]
Series X Redeemable Convertible Preferred Stock
Balance
Temporary equity, Balance (in shares)
Temporary equity, Balance
Balance (in shares)
Shares Outstanding
Stock-based compensation expense
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
Stock-based compensation expense
Stock Issued During Period Shares Share Based Compensation
Issuance of common stock from stock grants and option exercises
Stock Issued During Period From Stock Grants And Stock Options Exercised Value
Issuance of common stock from stock grants and option exercises, shares
Stock Issued During Period From Stock Grants And Stock Options Exercised Shares
Issuance of common stock for public offering, net of issuance costs
Stock Issued During Period Value New Issues
Issuance of common stock for public offering, net of issuance costs, shares
Stock Issued During Period Shares New Issues
Issuance of preferred stock upon acquisition of F351 Assets
Temporary Equity Issued During Period Value Acquisitions
Issuance of preferred stock upon acquisition of F351 Assets, shares
Temporary Equity Issued During Period Shares Acquisitions
Issuance of common stock upon acquisition of F351 Assets
Stock Issued During Period Value Acquisitions
Issuance of common upon acquisition of F351 Assets, shares
Stock Issued During Period Shares Acquisitions
Cash dividends paid ($1.43 per share)
Dividends Common Stock Cash
Cash dividends declared, unpaid ($0.24 per share)
Dividends Common Stock Stock
CVR derivative liability
C V R Derivative Liability
Balance
Temporary Equity, Balance (in shares)
Temporary Equity, Balance
Balance (in shares)
Issuance costs of issuance of common stock for public offering
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
Common stock, cash dividend paid
Common stock, cash dividend declared
Loss on lease termination.
Increase Decrease in operating lease liability and right-of-use asset.
Payment of transaction costs in connection with sale of complement portfolio.
Proceeds from issuance of common stock for secondary public offering, net of issuance costs.
Proceeds from issuance of common stock from stock grants and option exercises
Non cash or part non cash dividend declared, unpaid.
Right-of-use assets obtained in exchange for operating lease liabilities.
Remeasurement of right-of-use asset due to operating lease modification.
Statement Of Cash Flows [Abstract]
Operating Activities
Net Cash Provided By Used In Operating Activities [Abstract]
Net loss
Profit Loss
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]
Stock-based compensation expense
Share Based Compensation
Depreciation and amortization
Depreciation Depletion And Amortization
Bad debt expense
Provision For Doubtful Accounts
Loss on lease termination
Loss On Lease Termination
Net gain on disposal of assets
Changes in operating assets and liabilities:
Increase Decrease In Operating Capital [Abstract]
Accounts and other receivables
Increase Decrease In Accounts And Other Receivables
Prepaid and other current assets
Increase Decrease In Prepaid Deferred Expense And Other Assets
Accounts payable
Increase Decrease In Accounts Payable
Accrued compensation and other accrued liabilities
Increase Decrease In Accrued Liabilities
Operating lease liability and right-of-use asset
Increase Decrease In Operating Lease Liability And Right Of Use Asset
Deferred revenue
Increase Decrease In Contract With Customer Liability
Net cash flows used in operating activities
Net Cash Provided By Used In Operating Activities
Investing Activities
Net Cash Provided By Used In Investing Activities [Abstract]
Proceeds from maturities of short-term investments
Proceeds From Sale Maturity And Collection Of Shortterm Investments
Purchases of property and equipment
Payments To Acquire Property Plant And Equipment
Proceeds from the sale of property and equipment
Proceeds From Sale Of Property Plant And Equipment
Proceeds from the sale of complement portfolio to Vertex
Proceeds From Sale Of Intangible Assets
Payment of transaction costs in connection with sale of complement portfolio to Vertex
Payment Of Transaction Costs In Connection With Sale Of Complement Portfolio
Net cash flows provided by investing activities
Net Cash Provided By Used In Investing Activities
Financing Activities
Net Cash Provided By Used In Financing Activities [Abstract]
Issuance of common stock for public offering, net of issuance costs
Proceeds From Issuance Of Common Stock For Public Offering Net Of Issuance Costs
Payment of dividends
Payments Of Dividends
Issuance of common stock from stock grants and option exercises
Proceeds From Issuance Of Common Stock From Stock Grants And Option Exercises
Net cash flows (used in) provided by financing activities
Net Cash Provided By Used In Financing Activities
Net (decrease) increase in cash and cash equivalents
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
Cash and cash equivalents at beginning of the period
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
Cash and cash equivalents at end of the period
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Noncash Investing And Financing Items [Abstract]
Dividend declared, unpaid
Non Cash Or Part Non Cash Dividend Declared Unpaid
CVR derivative liability
Right-of-use assets obtained in exchange for operating lease liabilities
Non Cash Or Part Non Cash Right Of Use Assets Obtained In Exchange For Operating Lease Liabilities
Remeasurement of right-of-use asset due to operating lease modification
Non Cash Or Part Non Cash Remeasurement Of Right Of Use Asset Due To Operating Lease Modification
Documents Incorporated by Reference
Documents Incorporated By Reference [Text Block]
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Nature of Operations
Nature Of Operations
Liquidity
Liquidation Basis Of Accounting [Text Block]
Accounting Policies [Abstract]
Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
Business Combinations [Abstract]
F351 Asset Acquisition
Asset Acquisition [Text Block]
Fair Value Disclosures [Abstract]
Fair Value Measurements
Fair Value Disclosures [Text Block]
Investments All Other Investments [Abstract]
Financial Instruments
Financial Instruments Disclosure [Text Block]
Payables And Accruals [Abstract]
Other Accrued Liabilities
Accounts Payable Accrued Liabilities And Other Liabilities Disclosure Current [Text Block]
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies
Commitments Disclosure [Text Block]
Lessee Disclosure [Abstract]
Leases
Lessee Operating Leases [Text Block]
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock Based Compensation
Disclosure Of Compensation Related Costs Share Based Payments [Text Block]
Income Tax Disclosure [Abstract]
Income Taxes
Income Tax Disclosure [Text Block]
Collaborations
Collaborative Arrangement Disclosure [Text Block]
Other Income And Expenses [Abstract]
Interest and Other Income (Expense), Net
Other Nonoperating Income And Expense [Text Block]
Equity [Abstract]
Stockholders' Equity
Stockholders Equity Note Disclosure [Text Block]
Earnings Per Share [Abstract]
Net Loss per Share Attributable to Common Stockholders
Earnings Per Share [Text Block]
Restructuring And Related Activities [Abstract]
Restructuring
Restructuring And Related Activities Disclosure [Text Block]
Subsequent Events [Abstract]
Subsequent Events
Subsequent Events [Text Block]
Basis of Presentation
Basis Of Accounting Policy Policy [Text Block]
Use of Estimates
Use Of Estimates
Accounting Pronouncements Recently Adopted
New Accounting Pronouncements Policy Policy [Text Block]
Cash and Cash Equivalents
Cash And Cash Equivalents Policy [Text Block]
Fair Value of Financial Instruments
Fair Value Of Financial Instruments Policy
Derivative Financial Instruments
Derivatives Methods Of Accounting Hedging Derivatives
Property and Equipment
Property Plant And Equipment Policy [Text Block]
Investments
Marketable Securities Policy
Revenue Recognition
Revenue Recognition Policy [Text Block]
Cost of license and collaboration revenue policy.
Cost of License and Collaboration Revenue
Cost Of License And Collaboration Revenue Policy [Text Block]
Research and Development Expenses
Research And Development Expense Policy
Accrued research and development expenses.
Accrued Research and Development Expenses
Accrued Research And Development Expenses Policy [Text Block]
Acquired In-Research and Development
In Process Research And Development Policy
Concentration Risk Credit Risk
Concentration Risk Credit Risk
Concentration Risk Credit Risk Policy [Text Block]
Accounts Receivable, net and Allowance for Doubtful Accounts
Receivables Trade And Other Accounts Receivable Allowance For Doubtful Accounts Policy
Income Taxes
Income Tax Policy [Text Block]
Stock-Based Compensation
Share Based Compensation Option And Incentive Plans Policy
Restructuring Charges
Costs Associated With Exit Or Disposal Activities Or Restructurings Policy
Leases
Lessee Leases Policy [Text Block]
Redeemable Convertible Preferred Stock
Stockholders Equity Note Redeemable Preferred Stock Issue Policy
Net Loss per Share
Earnings Per Share Policy [Text Block]
Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis
Fair Value Assets Measured On Recurring Basis [Text Block]
Cash Equivalents and Investments (Debt Securities) Classified as Available-for-sale Securities
Schedule Of Cash Cash Equivalents And Short Term Investments Table [Text Block]
Schedule of Other Accrued Liabilities
Schedule Of Accrued Liabilities Table [Text Block]
Summary of present value assumptions of lease payments.
Summary of Present Value Assumptions used in Calculating Present Value of Lease Payments
Summary Of Present Value Assumptions Of Lease Payments Table [Text Block]
Schedule of Maturity of Operating Lease Liabilities
Lessee Operating Lease Liability Maturity Table [Text Block]
Schedule of Supplemental Cash Flow Information
Schedule Of Cash Flow Supplemental Disclosures Table [Text Block]
Summary of Option Activity Under Company's Equity Incentive Plans
Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]
Summary of Weighted Average Valuation Assumptions Used to Estimate Fair Value of Employee Stock Options
Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]
Summary of Stock-Based Compensation Recognized
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]
Components of Provision for Income Taxes
Schedule Of Components Of Income Tax Expense Benefit Table [Text Block]
Reconciliation of Federal Statutory Income Tax Rate to Company's Effective Tax Rate
Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]
Significant Components of the Company's Deferred Tax Assets
Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]
Reconciliation of Beginning and Ending Balance of Unrecognized Tax Benefits
Schedule Of Unrecognized Tax Benefits Roll Forward Table [Text Block]
Detail of Interest and Other Income (Expense), Net
Schedule Of Other Nonoperating Income Expense Table [Text Block]
Anti-dilutive Security not Included in Diluted per Share Calculations
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]
Summary of Restructuring Charges Recorded in Component of Operating Expenses
Schedule Of Restructuring And Related Costs [Text Block]
Organization and nature of operations.
Organization and Nature of Operations [Table]
Organization And Nature Of Operations [Table]
Organization And Nature Of Operations [Table]
Convertible Preferred Stock
Convertible Preferred Stock [Member]
Asset Acquisition
Asset Acquisition [Axis]
Asset Acquisition
Asset Acquisition [Domain]
F351 asset purchase agreement.
F351 Agreement
F Three Five One Asset Purchase Agreement [Member]
Organization and Nature of Operations [Line Items]
Organization And Nature Of Operations [Line Items]
Number of operating segment
Number Of Operating Segments
Assets acquisition, paid
Asset Acquisition Consideration Transferred Equity Interest Issued And Issuable
Assets acquisition, shares issued
Preferred stock shares issued
Preferred Stock Shares Issued
Preferred stock, shares issued upon conversion of common stock
Convertible Preferred Stock Shares Issued Upon Conversion
Percentage of Commission for shares sold.
Liquidity.
Liquidity [Abstract]
Liquidity.
Liquidity.
Liquidity [Table]
Liquidity [Table]
Sale of Stock
Subsidiary Sale Of Stock [Axis]
Sale of Stock
Sale Of Stock Name Of Transaction [Domain]
Two thousand twenty one ATM program.
2021 ATM Program
Two Thousand Twenty One A T M Program [Member]
Liquidity [Line Items]
Liquidity [Line Items]
Percentage of commission for shares sold
Percentage Of Commission For Shares Sold
Accumulated deficit
Cash, cash equivalents and short-term investments
Cash Cash Equivalents And Short Term Investments
Net loss
Aggregate amount of special dividend payment
Payments Of Dividends Common Stock
Common stock, dividend payable, date of record
Dividends Payable Date Of Record Day Month And Year
Conversion of stock shares, issued
Stock Issued During Period Shares Conversion Of Convertible Securities
Cash dividends payable per common share
Dividends Payable Amount Per Share
Summary of significant accounting policies.
Summary of significant accounting policies.
Summary Of Significant Accounting Policies [Table]
Summary Of Significant Accounting Policies [Table]
Accounting Standards Update
Adjustments For New Accounting Pronouncements [Axis]
Accounting Standards Update
Type Of Adoption [Member]
ASU 2021-04
Accounting Standards Update202104 [Member]
ASU 2020-06
Accounting Standards Update202006 [Member]
Long-Lived Tangible Asset
Property Plant And Equipment By Type [Axis]
Long-Lived Tangible Asset
Property Plant And Equipment Type [Domain]
Computer equipment
Computer Equipment [Member]
Furniture
Furniture And Fixtures [Member]
Leasehold improvements
Leasehold Improvements [Member]
Finite-Lived Intangible Assets by Major Class
Finite Lived Intangible Assets By Major Class [Axis]
Finite-Lived Intangible Assets, Major Class Name
Finite Lived Intangible Assets Major Class Name [Domain]
Software
Computer Software Intangible Asset [Member]
Statistical Measurement
Range [Axis]
Statistical Measurement
Range [Member]
Minimum
Minimum [Member]
Maximum
Maximum [Member]
Income Statement Location
Income Statement Location [Axis]
Income Statement Location
Income Statement Location [Domain]
Research and Development Expense
Research And Development Expense [Member]
Summary Of Significant Accounting Policies [Line Items]
Summary Of Significant Accounting Policies [Line Items]
Change in accounting principle, accounting standards update, adoption date
Change In Accounting Principle Accounting Standards Update Adoption Date
Change in accounting principle, accounting standards update, adopted
Change In Accounting Principle Accounting Standards Update Adopted
Change in accounting principle, accounting standards update, immaterial effect
Change In Accounting Principle Accounting Standards Update Immaterial Effect
Estimated useful lives
Property Plant And Equipment Useful Life
Cost of collaboration revenue.
Cost of collaboration revenue
Cost Of Collaboration Revenue
Accounts receivable, allowance for doubtful accounts
Allowance For Doubtful Accounts Receivable
Concentration of credit risk
Concentration Risk Credit Risk Financial Instrument Maximum Exposure
Asset Acquisition [Table]
Asset Acquisition [Table]
Asset Acquisition [Line Items]
Asset Acquisition [Line Items]
Asset acquisition recognized identifiable assets acquired and liabilities assumed other liabilities.
Asset acquisition recognized identifiable assets acquired and liabilities assumed, other assets.
Assets acquisition, cost
Asset Acquisition Consideration Transferred
Asset acquisition, direct cost
Asset Acquisition Consideration Transferred Transaction Cost
Asset acquisition, assumed other assets
Asset Acquisition Recognized Identifiable Assets Acquired And Liabilities Assumed Other Assets
Asset acquisition, assumed liabilities
Asset Acquisition Recognized Identifiable Assets Acquired And Liabilities Assumed Other Liabilities
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Cash and Cash Equivalents
Cash And Cash Equivalents [Axis]
Cash and Cash Equivalents
Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Member]
Money Market Funds
Money Market Funds [Member]
CVR derivative liability.
CVR Derivative Liability
C V R Derivative Liability [Member]
Fair Value Hierarchy and NAV
Fair Value By Fair Value Hierarchy Level [Axis]
Fair Value Hierarchy and NAV
Fair Value Measurements Fair Value Hierarchy [Domain]
Fair Value, Inputs, Level 1
Fair Value Inputs Level1 [Member]
Fair Value, Inputs, Level 3
Fair Value Inputs Level3 [Member]
Investment Type
Investment Type [Axis]
Investments
Investment Type Categorization [Member]
U.S. Government Agency Securities
U S Government Agencies Debt Securities [Member]
Fair Value, Inputs, Level 2
Fair Value Inputs Level2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Assets, fair value
Assets Fair Value Disclosure
Liabilities, fair value
Liabilities Fair Value Disclosure
Derivative liabilities estimated fair value increase decrease.
Amount to be received under agreement.
Contingent value rights dividend derivative liability.
Fair Value By Balance Sheet Grouping [Table]
Fair Value By Balance Sheet Grouping [Table]
Contingent Value Rights Agreement.
Contingent Value Rights Agreement
Contingent Value Rights Agreement [Member]
Scenario
Statement Scenario [Axis]
Scenario
Scenario Unspecified [Domain]
Forecast
Scenario Forecast [Member]
Vertex Asset Purchase Agreement.
Vertex Asset Purchase Agreement
Vertex Asset Purchase Agreement [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Amount to be received under agreement
Amount To Be Received Under Agreement
Initial derivative liability
Contingent Value Rights Dividend Derivative Liability
Change in the estimated fair value
Derivative Liabilities Estimated Fair Value Increase Decrease
Investments Debt And Equity Securities [Abstract]
Schedule Of Available For Sale Securities [Table]
Schedule Of Available For Sale Securities [Table]
Financial Instrument
Financial Instrument [Axis]
Financial Instruments
Transfers And Servicing Of Financial Instruments Types Of Financial Instruments [Domain]
Cash and Cash Equivalents
Cash And Cash Equivalents [Member]
Short-Term Investments
Short Term Investments [Member]
Schedule Of Available For Sale Securities [Line Items]
Schedule Of Available For Sale Securities [Line Items]
Amortized Cost
Available For Sale Debt Securities Amortized Cost Basis
Gross Unrealized Gains
Accumulated Gross Unrealized Gain Before Tax Available For Sale Securities
Gross Unrealized Losses
Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
Estimated Fair Value
Available For Sale Securities Debt Securities
Material realized gains or losses on available-for-sale securities
Debt Securities Available For Sale Realized Gain Loss
Available-for-sale debt securities current
Available For Sale Securities Debt Securities Current
Accrued manufacturing expenses current.
Accrued collaboration expenses current.
Accrued Pre Clinical Expenses Current.
Accrued clinical expenses current.
Accrued and other current liabilities.
Professional and consulting services
Accrued Professional Fees Current
Manufacturing
Accrued Manufacturing Expenses Current
Biogen
Accrued Collaboration Expenses Current
Pre-clinical
Accrued Pre Clinical Expenses Current
Clinical
Accrued Clinical Expenses Current
Other
Accrued And Other Current Liabilities
Total other accrued liabilities
Termination fee required to pay upon termination of agreement.
Reimbursement for out-of-pocket fees and expenses.
Commitments and contingencies disclosure.
Commitments and contingencies disclosure.
Commitments And Contingencies Disclosure [Table]
Commitments And Contingencies Disclosure [Table]
Counterparty Name
Counterparty Name [Axis]
Counterparty Name
Repurchase Agreement Counterparty Name [Domain]
F three five one.
F351
F Three Five One [Member]
GNI
G N I
G N I [Member]
Business Acquisition
Business Acquisition [Axis]
Business Acquisition, Acquiree
Business Acquisition Acquiree [Domain]
Business combination agreement.
Business Combination Agreement
Business Combination Agreement [Member]
Dalcinonacog alfa.
Dalcinonacog Alfa
Dalcinonacog Alfa [Member]
Service Agreements
Service Agreements [Member]
Integrity bio .
Catalent Indiana, LLC.
Integrity Bio [Member]
GMP manufacturing.
Dalcinonacog alfa.
G M P [Member]
Legal and other expenses.
Legal and Other Expenses
Legal And Other Expenses [Member]
Commitments And Contingencies Disclosure [Line Items]
Commitments And Contingencies Disclosure [Line Items]
Common stock, shares issued
Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued
Termination fee required to pay upon termination of agreement
Termination Fee Required To Pay Upon Termination Of Agreement
Reimbursement for out-of-pocket fees and expenses
Reimbursement For Out Of Pocket Fees And Expenses
Percentage of excess cash on dispositions net.
Excess amount retained from net proceeds related to disposition of assets.
Percentage of amount received on agreement.
Percentage of excess preapproved costs.
Percentage of excess cash on dispositions net
Percentage Of Excess Cash On Dispositions Net
Excess amount retained from net proceeds related to disposition of assets
Excess Amount Retained From Net Proceeds Related To Disposition Of Assets
Percentage of amount received on agreement
Percentage Of Amount Received On Agreement
Percentage of excess preapproved costs
Percentage Of Excess Preapproved Costs
Cost of services as per agreement.
Clinical trial services cost incurred on agreement termination.
Cost of services as per agreement
Cost Of Services As Per Agreement
Remaining obligations
Contractual Obligation
Clinical trial services cost incurred on agreement termination
Clinical Trial Services Cost Incurred On Agreement Termination
Firm work order supporting clinical trials.
Firm work order supporting clinical trials
Firm Work Order Supporting Clinical Trials
Percentage of common stock filed a lawsuit.
Litigation amount .
Percentage of common stock filed a lawsuit
Percentage Of Common Stock Filed Lawsuit
Litigation amount
Litigation Amount
Lessee operating lease renewal term description.
Lessee Lease Description [Table]
Lessee Lease Description [Table]
Related Party
Related Party Transactions By Related Party [Axis]
Related Party
Related Party [Domain]
Lease lab and office space.
Lease Lab And Office Space
Lease Lab And Office Space [Member]
Collaborative Arrangement and Arrangement Other than Collaborative
Type Of Arrangement [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative
Arrangements And Nonarrangement Transactions [Member]
Sublease arrangement.
Sublease Arrangement
Sublease Arrangement [Member]
General and Administrative
General And Administrative Expense [Member]
Lessee Lease Description [Line Items]
Lessee Lease Description [Line Items]
Lease expiration date
Lease Expiration Date1
Lessee operating lease renewal term description
Lessee Operating Lease Renewal Term Description
License agreement termination month and year.
Right-of-use asset and lease liability
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
Undiscounted future payment
Lessee Operating Lease Liability Payments Due
Operating lease commenced description
Lessee Operating Lease Description
License agreement termination month and year
License Agreement Termination Month And Year
Lease commencement month and year.
Lease expiration month and year.
Lease commencement month and year
Lease Commencement Month And Year
Lease payments receivable
Lessor Operating Lease Payments To Be Received
Lease expiration month and year
Lease Expiration Month And Year
Sublease Income
Sublease Income
Payment of termination fees.
Termination fees paid
Payment Of Termination Fees
Operating lease, liability
Operating Lease Liability
Loss on lease termination
Gain Loss On Termination Of Lease
Operating lease expense
Operating Lease Expense
Weighted-average remaining lease term
Operating Lease Weighted Average Remaining Lease Term1
Weighted-average discount rate
Operating Lease Weighted Average Discount Rate Percent
Operating Lease Liabilities Payments Due [Abstract]
2023
Lessee Operating Lease Liability Payments Due Next Twelve Months
Total undiscounted lease payments
Less: imputed interest
Lessee Operating Lease Liability Undiscounted Excess Amount
Cash paid for amounts included in the measurement of lease liabilities.
Prepaid Cash Payment For Lease Liabilities.
Cash paid for amounts included in the measurement of lease liabilities
Cash Paid For Amounts Included In The Measurement Of Lease Liabilities
Prepaid cash payment for lease
Prepaid Cash Payment For Lease Liabilities
Cash paid for operating leases that were included in operating cash outflows
Operating Lease Payments
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Plan Name
Plan Name [Axis]
Plan Name
Plan Name [Domain]
Two thousand eighteen omnibus incentive plan.
2018 Omnibus Incentive Plan
Two Thousand Eighteen Omnibus Incentive Plan [Member]
Award Type
Award Type [Axis]
Award Type
Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]
Performance based stock option grants.
Performance-Based Stock Option Grants
Performance Based Stock Option Grants [Member]
Employee Stock Option
Employee Stock Option [Member]
Two thousand eighteen employee stock purchase plan.
2018 Employee Stock Purchase Plan
Two Thousand Eighteen Employee Stock Purchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Increase in number of shares of common stock reserved for issuance
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease
Common stock, capital shares reserved for future issuance
Common Stock Capital Shares Reserved For Future Issuance
Number of common stock available for future grant
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
Issuance of option grants to purchase common stock shares.
Issuance of option grants to purchase common stock shares
Issuance Of Option Grants To Purchase Common Stock Shares
Options vested
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
Aggregate amount of special dividend payment
Number of Shares Underlying Outstanding Options
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward
Number of Shares Underlying Outstanding Options, Beginning Balance
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
Number of Shares Underlying Outstanding Options, Options granted
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
Number of Shares Underlying Outstanding Options, Options forfeited and cancelled
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
Number of Shares Underlying Outstanding Options, Options expired
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
Number of Shares Underlying Outstanding Options, Ending Balance
Number of Shares Underlying Outstanding Options, Exercisable- December 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
Weighted- Average Exercise Price
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward
Weighted- Average Exercise Price, Beginning Balance
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
Weighted- Average Exercise Price, Options granted
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
Weighted- Average Exercise Price, Options forfeited and cancelled
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
Weighted- Average Exercise Price, Options expired
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
Weighted- Average Exercise Price, Ending Balance
Weighted- Average Exercise Price, Exercisable - December 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
Weighted-Average Remaining Contractual Term (Years)
Share Based Compensation Arrangement By Share Based Payment Award Options Additional Disclosures [Abstract]
Weighted-Average Remaining Contractual Term (Years), Outstanding Balance
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
Weighted Average Remaining Contractual Term, Exercisable - December 31, 2022
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
Aggregate Intrinsic Value
Share Based Compensation Arrangement By Share Based Payment Award Additional General Disclosures [Abstract]
Aggregate Intrinsic Value, Outstanding
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
Weighted average grant date fair value of stock options
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
Option exercised
Stock Issued During Period Shares Stock Options Exercised
Aggregate intrinsic value of options exercised
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
Fair value of options vested
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
Share based compensation arrangement by share based payment award fair value assumptions Black-Scholes method used.
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Black-Scholes Method Used [Table]
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Black Scholes Method Used [Table]
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Black Scholes Method Used [Table]
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Black Scholes Method Used [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Black Scholes Method Used [Line Items]
Expected term (in years)
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
Risk-free interest rate
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
Dividend yield
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
Volatility
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Research and development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Total stock-based compensation
Allocated Share Based Compensation Expense
Number of shares of common stock issued to certain board members in lieu of cash compensation
Stock Issued During Period Shares Issued For Services
Unrecognized employee stock based compensation expense
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
Unrecognized employee stock based compensation expense, period for recognition
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
Percentage of fair market value of common stock
Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
Maximum employee subscription rate
Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate
Number of common stock authorized for issuance
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
Number of common stock stock issued
Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
Proceeds from Issuance
Proceeds From Issuance Or Sale Of Equity
Current tax provision:
Current Federal State And Local Tax Expense Benefit [Abstract]
Federal
Current Federal Tax Expense Benefit
State
Current State And Local Tax Expense Benefit
Total tax provision
Current Federal State And Local Tax Expense Benefit
Effective income tax rate reconciliation, permanent differences.
Effective income tax rate reconciliation derecognition.
Effective income tax rate reconciliation, fixed assets other adjustment, percent.
Tax at statutory federal rate
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
State Tax (benefit)—net of federal benefit
Effective Income Tax Rate Reconciliation State And Local Income Taxes
Permanent differences
Effective Income Tax Rate Reconciliation Permanent Differences
Tax credits
Effective Income Tax Rate Reconciliation Tax Credits
Derecognition due to Sec. 382 and 383 limitations
Effective Income Tax Rate Reconciliation Derecognition
Change in valuation allowance
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
Fixed assets other adjustment
Effective Income Tax Rate Reconciliation Fixed Assets Other Adjustment Percent
Other
Effective Income Tax Rate Reconciliation Nondeductible Expense Other
Effective tax rate
Effective Income Tax Rate Continuing Operations
Deferred tax assets fixed assets and intangibles.
Deferred tax assets:
Deferred Tax Assets Gross [Abstract]
Accruals and reserves
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
Net operating loss carry forwards
Deferred Tax Assets Operating Loss Carryforwards
Tax credit carry forwards
Deferred Tax Assets Tax Credit Carryforwards Research
Fixed and intangible assets
Deferred Tax Assets Fixed Assets And Intangibles
Valuation allowance
Deferred Tax Assets Valuation Allowance
Net deferred tax assets:
Deferred Tax Assets Net
Income Tax.
Income Tax [Table]
Income Tax [Table]
Income Tax [Table]
Income Tax Authority
Income Tax Authority [Axis]
Income Tax Authority
Income Tax Authority [Domain]
Federal Income Tax
Domestic Country [Member]
State Income Tax
State And Local Jurisdiction [Member]
CALIFORNIA
CALIFORNIA
Income Tax [Line Items]
Income Tax [Line Items]
Increase (decrease) in valuation allowance
Valuation Allowances And Reserves Period Increase Decrease
Operating loss carryforwards expiration year.
Operating loss carryforwards with indefinite life.
Net operating loss carryforwards
Operating Loss Carryforwards
Net operating loss carryforwards expiration year
Operating Loss Carryforwards Expiration Year
Net operating loss carryforwards having indefinite life
Operating Loss Carryforwards With Indefinite Life
Tax credit carryforward expiration year.
Tax credit carryforwards available to offset future federal tax liabilities
Tax Credit Carryforward Amount
Credit carryforward, expire year
Tax Credit Carryforward Expiration Year
Deferred tax assets state net operating loss carry forwards.
Net operating loss carryforward, derecognized
Deferred Tax Assets State Net Operating Loss Carry Forwards
Research and development tax credit carry forwards derecognized.
Gross federal R&D credit-related deferred tax assets derecognized
Research And Development Tax Credit Carry Forwards Derecognized
Maximum amount of tax offset per year.
The minimum taxable income required to support realizing the company's.
Maximum amount of tax offset per year
Maximum Amount Of Tax Offset Per Year
Required Minimum Taxable Income
Required Minimum Taxable Income
Unrecognized tax benefit
Unrecognized Tax Benefits
Unrecognized tax benefits increase (decrease) resulting from tax positions.
Beginning Balance
Increase/(Decrease) of unrecognized tax benefits taken in prior years
Unrecognized Tax Benefits Increase Decrease Resulting From Prior Period Tax Positions
Increase/(Decrease) of unrecognized tax benefits related to current year
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
Ending Balance
Tax-related penalties or interest recognized
Income Tax Examination Penalties And Interest Accrued
Uncertain tax positions
Liability For Uncertain Tax Positions Current
Milestone payment .
Collaboration agreements.
Collaboration Agreements [Abstract]
Revenue Recognition Multiple Deliverable Arrangements [Table]
Revenue Recognition Multiple Deliverable Arrangements [Table]
Mosaic Biosciences, Inc.
Mosaic Biosciences Inc
Mosaic Biosciences Inc [Member]
ISU Abxis.
ISU Abxis
Isu Abxis [Member]
Transaction Type
Transaction Type [Axis]
Transaction
Transaction [Domain]
Amended and restated license agreement.
Amended and Restated License Agreement
Amended And Restated License Agreement [Member]
Biogen.
Biogen
Biogen [Member]
Exclusive license.
Exclusive License
Exclusive License [Member]
Exclusive License
Termination agreement.
Termination Agreement
Termination Agreement [Member]
Collaboration
Research and Development Arrangement, Contract to Perform for Others, Type
Research And Development Arrangement Contract To Perform For Others By Type [Axis]
Research and Development Arrangement, Contract to Perform for Others, Type
Research And Development Arrangement Contract To Perform For Others Type [Domain]
Reimbursable Out-of-Pocket and Personnel Costs Incurred Related to Research Services.
Reimbursable Out-of-Pocket and Personnel Costs Incurred Related to Research Services
Reimbursable Out Of Pocket And Personnel Costs Incurred Related To Research Services [Member]
Revenue Recognition Multiple Deliverable Arrangements [Line Items]
Revenue Recognition Multiple Deliverable Arrangements [Line Items]
Milestone payment related to regulatory and clinical development events
Milestone Payment Related To Regulatory And Clinical Development Events
Milestone payments.
Regulatory and development milestone payment.
Commercial milestone payments.
Milestone payment
Milestone Payments
Regulatory and development milestone payment
Regulatory And Development Milestone Payment
Commercial milestone payments
Commercial Milestone Payments
Development and sales milestone payments.
Up-front payments received
Proceeds From License Fees Received
Development and sales milestone payments
Development And Sales Milestone Payments
Forgiveness of accounts receivable, net.
Payments to cash.
Settlement expense.
Forgiveness of accounts receivable, net
Forgiveness Of Accounts Receivable Net
Payments to cash
Payments To Cash
Settlement expense
Settlement Expense
Deferred revenue, recognized
Deferred Revenue Revenue Recognized1
Gain (loss) from extinguishment of liability.
Interest income
Interest Income Expense Nonoperating Net
Gain from extinguishment of liability
Gain Loss From Extinguishment Of Liability
Other
Other Nonoperating Income Expense
Total interest and other income (expense), net
Stockholders equity disclosure.
Stockholders equity disclosure.
Stockholders Equity Disclosure [Table]
Stockholders Equity Disclosure [Table]
Warrants
Warrant [Member]
Subsequent Event Type
Subsequent Event Type [Axis]
Subsequent Event Type
Subsequent Event Type [Domain]
Subsequent Event
Subsequent Event [Member]
Stockholders Equity Disclosure [Line Items]
Stockholders Equity Disclosure [Line Items]
Common Stock, voting rights
Common Stock Voting Rights
Warrant expiration month and year.
Common stock issued
Common stock outstanding
Warrants exercise price per share
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
Warrant expiration month and year
Warrant Expiration Month And Year
Legal expenses incurred.
Legal expenses incurred
Legal Expenses Incurred
Preferred stock shares authorized
Preferred Stock Shares Authorized
Preferred stock par value per share
Preferred Stock Par Or Stated Value Per Share
Preferred stock, shares outstanding
Preferred Stock Shares Outstanding
Conversion of outstanding preferred stock redeemed for cash.
Conversion of outstanding preferred stock redeemed for cash
Conversion Of Outstanding Preferred Stock Redeemed For Cash
Affiliates beneficial own shares percentage.
Affiliates beneficial own shares specified percentage.
Affiliates beneficial own shares percentage
Affiliates Beneficial Own Shares Percentage
Affiliates beneficial own shares specified percentage
Affiliates Beneficial Own Shares Specified Percentage
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Antidilutive Securities
Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]
Antidilutive Securities, Name
Antidilutive Securities Name [Domain]
Options to purchase common stock.
Options To Purchase Common Stock
Options To Purchase Common Stock [Member]
Common stock warrants.
Common Stock Warrants
Common Stock Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti dilutive securities
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
Charges related to write off of prepaid manufacturing costs.
Restructuring liability.
Schedule Of Restructuring And Related Costs [Table]
Schedule Of Restructuring And Related Costs [Table]
Operating Expense
Operating Expense [Member]
Dren Bio, Inc. and Copia Scientific, LLC.
Dren Bio, Inc. and Copia Scientific, LLC
Dren Bio Inc And Copia Scientific L L C [Member]
Vertex pharmaceuticals incorporated.
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated [Member]
Restructuring Cost And Reserve [Line Items]
Restructuring Cost And Reserve [Line Items]
Percent of employees terminated
Restructuring And Related Cost Number Of Positions Eliminated Period Percent
Severance costs and expenses
Severance Costs1
Charges related to write off of prepaid manufacturing cost
Charges Related To Write Off Of Prepaid Manufacturing Cost
Restructuring liability
Restructuring Liability
Remaining number of full time employees.
Severance and other costs.
Number of employees terminated
Restructuring And Related Cost Number Of Positions Eliminated
Remaining number of full time employees
Remaining Number Of Full Time Employees
Severance and other charges
Severance And Other Costs
Total restructuring charges
Restructuring Charges
Total consideration for sales agreements
Disposal Group Including Discontinued Operation Consideration
Gain (loss) on disposal
Upfront payment received.
Post closing indemnification obligation.
Disposal of assets transaction costs.
Upfront payment received
Upfront Payment Received
Post closing indemnification obligation
Post Closing Indemnification Obligation
Transaction costs
Disposal Of Assets Transaction Costs
Subsequent Event [Table]
Subsequent Event [Table]
GC Biopharma Corp.
GC Biopharma Corp
G C Biopharma Corp [Member]
Subsequent Event [Line Items]
Subsequent Event [Line Items]
Dividends Payable, date declared
Dividends Payable Date Declared Day Month And Year
Dividend declared
Number of bank accounts.
Number of bank accounts
Number Of Bank Accounts
Cash deposit
Deposit Assets